NO20055025D0 - Multiplex screening for lysosomale lagringsforstyrrelser (LSD) - Google Patents

Multiplex screening for lysosomale lagringsforstyrrelser (LSD)

Info

Publication number
NO20055025D0
NO20055025D0 NO20055025A NO20055025A NO20055025D0 NO 20055025 D0 NO20055025 D0 NO 20055025D0 NO 20055025 A NO20055025 A NO 20055025A NO 20055025 A NO20055025 A NO 20055025A NO 20055025 D0 NO20055025 D0 NO 20055025D0
Authority
NO
Norway
Prior art keywords
lsd
lysosomal
lysosomal storage
proteins
storage disorders
Prior art date
Application number
NO20055025A
Other languages
English (en)
Other versions
NO20055025L (no
Inventor
Peter John Meikle
John Joseph Hopwood
Douglas Alexander Brooks
Caroline Dean
Original Assignee
Womens & Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2003901451A external-priority patent/AU2003901451A0/en
Priority claimed from AU2003904174A external-priority patent/AU2003904174A0/en
Priority claimed from AU2003904720A external-priority patent/AU2003904720A0/en
Application filed by Womens & Childrens Hospital filed Critical Womens & Childrens Hospital
Publication of NO20055025D0 publication Critical patent/NO20055025D0/no
Publication of NO20055025L publication Critical patent/NO20055025L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0058—Antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0089—Particulate, powder, adsorbate, bead, sphere
    • A61K49/0091—Microparticle, microcapsule, microbubble, microsphere, microbead, i.e. having a size or diameter higher or equal to 1 micrometer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
NO20055025A 2003-03-31 2005-10-28 Multiplex screening for lysosomale lagringsforstyrrelser (LSD) NO20055025L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AU2003901451A AU2003901451A0 (en) 2003-03-31 2003-03-31 An improved method of screening for lysosomal storage disorders (LSD)
AU2003904174A AU2003904174A0 (en) 2003-08-08 2003-08-08 Multiplex screening for lysosomal storagge disorders (lsds)
AU2003904720A AU2003904720A0 (en) 2003-09-01 Multiplex screening for lysosomal storage disorders (LSDs)
PCT/AU2004/000403 WO2004088322A1 (en) 2003-03-31 2004-03-31 MULTIPLEX SCREENING FOR LYSOSOMAL STORAGE DISORDERS (LSDs)

Publications (2)

Publication Number Publication Date
NO20055025D0 true NO20055025D0 (no) 2005-10-28
NO20055025L NO20055025L (no) 2006-01-02

Family

ID=33135374

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055025A NO20055025L (no) 2003-03-31 2005-10-28 Multiplex screening for lysosomale lagringsforstyrrelser (LSD)

Country Status (8)

Country Link
US (2) US8173443B2 (no)
EP (1) EP1616193B1 (no)
JP (1) JP4833831B2 (no)
AT (1) ATE550664T1 (no)
CA (1) CA2524272A1 (no)
NO (1) NO20055025L (no)
NZ (1) NZ543309A (no)
WO (1) WO2004088322A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7615224B2 (en) 2004-12-02 2009-11-10 Women's And Children's Hospital Multiplex-bead complex for determination of lysosomal storage disorders
US8765690B2 (en) * 2007-04-05 2014-07-01 Threshold Pharmaceuticals, Inc. Treatment of cancer with glufosfamide in patients not receiving insulin therapy
US8497122B2 (en) 2008-04-11 2013-07-30 Washington University Biomarkers for Niemann-pick C disease and related disorders
US20120003225A1 (en) * 2008-05-09 2012-01-05 Duke University Autoantibodies in the detection and treatment of cancer
GB201114909D0 (en) * 2011-08-30 2011-10-12 San Raffaele Centro Fond Biomarkers for lysosomal storage disorders
AU2013240942B2 (en) * 2012-03-30 2018-07-05 Junichiro Futami Method for producing reagent for antibody detection and use thereof
US10302664B2 (en) * 2013-05-14 2019-05-28 Centogene Ag Method for the diagnosis of Niemann-Pick disease
US10196668B2 (en) 2013-09-05 2019-02-05 University Of Washington Through Its Center For Commercialization Reagents and methods for screening MPS I, II, IIIA, IIIB, IVA, VI, and VII
CN106018303A (zh) * 2016-07-12 2016-10-12 安徽伊普诺康生物技术股份有限公司 一种测定α-L-岩藻糖苷酶的试剂盒
JP2023519969A (ja) * 2020-03-31 2023-05-15 シアトル・チルドレンズ・ホスピタル・ドゥーイング／ビジネス／アズ・シアトル・チルドレンズ・リサーチ・インスティテュート リソソーム蓄積症に関するプロテオミクススクリーニング
CN113049715B (zh) * 2021-03-31 2023-03-17 宝枫生物科技（北京）有限公司 用于诊断脑白质病变的生物标志物及其应用
WO2024018382A1 (en) 2022-07-19 2024-01-25 Genzyme Corporation Biomarkers of lysosomal storage disease

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994010340A1 (en) * 1992-10-30 1994-05-11 Mt. Sinai Hospital Corporation Method for measuring glycosyltransferase activity
WO1997014028A2 (en) 1995-10-11 1997-04-17 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and method
AUPN991796A0 (en) 1996-05-17 1996-06-13 Women's And Children's Hospital Early detection of lysosomal storage disorders
AU714818B2 (en) * 1996-05-17 2000-01-13 Women's And Children's Hospital Early detection of lysosomal storage disorders
US6449562B1 (en) 1996-10-10 2002-09-10 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and method
GB9908190D0 (en) * 1999-04-09 1999-06-02 Pharming Intellectual Pty Bv Diagnosis of lysosomal storage disorders using saposins and other markers
KR20020021775A (ko) 1999-03-17 2002-03-22 위민즈 앤드 칠드런즈호스피틀 사포신 및 기타 마커를 사용하는 리소좀 축적 질환의 진단방법
US7465540B2 (en) 2000-09-21 2008-12-16 Luminex Corporation Multiple reporter read-out for bioassays
AUPS293002A0 (en) 2002-06-14 2002-07-04 Women's And Children's Hospital Identification of oligosaccharides and their use in the diagnosis and evaluation of mucopolysaccharidoses and other related disorders
US7615224B2 (en) * 2004-12-02 2009-11-10 Women's And Children's Hospital Multiplex-bead complex for determination of lysosomal storage disorders

Also Published As

Publication number Publication date
US8173443B2 (en) 2012-05-08
ATE550664T1 (de) 2012-04-15
US20070072243A1 (en) 2007-03-29
CA2524272A1 (en) 2004-10-14
NO20055025L (no) 2006-01-02
JP4833831B2 (ja) 2011-12-07
WO2004088322A1 (en) 2004-10-14
NZ543309A (en) 2008-12-24
US20120184050A1 (en) 2012-07-19
EP1616193A4 (en) 2006-07-05
JP2006523300A (ja) 2006-10-12
US8735173B2 (en) 2014-05-27
EP1616193A1 (en) 2006-01-18
EP1616193B1 (en) 2012-03-21

Similar Documents

Publication Publication Date Title
NO20055025D0 (no) Multiplex screening for lysosomale lagringsforstyrrelser (LSD)
BRPI0208597B8 (pt) meio de detecção de staphylococcus aureus e/ou estafilococos com coagulose positiva e método de identificação de bactéria (s) da espécie staphylococcus aureus em uma amostra
WO2004046729A3 (en) Bodily fluid markers of tissue hypoxia
WO2006055739A3 (en) Stationary phase antibody arrays for trace protein analysis
DK0944731T3 (da) Enzymsensor
WO2001027624A3 (en) Compositions and methods for detecting protein modification and enzymatic activity
DE69938662D1 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
ATE337413T1 (de) Methoden zur verbesserung der sensitivität und spezifität von screeningverfahren für krebs und krebs-vorstufen
GB0524110D0 (en) Biomarkers and methods for identification of agents useful in the treatment of affective disorders
ATE494548T1 (de) Reinigung, charakterisierung und wiederherstellung einer ubiquitin-e3-ligase
WO2003087760A3 (en) Methods for detecting bcr-abl signaling activity in tissues using phospho- specific antibodies
TW200504223A (en) Methods of assessment of drug metabolizing enzymes
DE602005023329D1 (de) VERFAHREN ZUR DIAGNOSE NICHT-KLEINZELLIGER LUNGENKARZINOME ÜBER DIE tRNA-DIHYDROURIDIN-SYNTHASEAKTIVITÄT VON URLC8
DK1095032T3 (da) Hidtil ukendte fluorescerende CYP2D-assayreagenser
FR2875242B1 (fr) Nouveaux substrats enzymatiques derives de phenoxazinone et leur utilisation comme revelateur dans la detection de microorganismes a activite peptidase
DE60332479D1 (de) Holo-transcobalamin bindungspartner und ihre verwendung in cobalamintest
ATE424562T1 (de) Diagnose von lysosomalen speicherungskrankheiten unter verwendung von saposinen und anderen markern
DE60230988D1 (de) Proteine in der diabetes-proteomanalyse
ATE405828T1 (de) Biomarker zur reaktionsüberwachung von cdk- hemmern in der klinik
WO2004050682A3 (en) Phosphospecific pak antibodies and diagnostic kits
WO2006026808A8 (en) Method of diagnosing and/or predicting the development of an allergic disorder
EP1529849A8 (en) Reliable method for assessing and reporting the risks of disease, contamination and losses caused by one or more microorganisms in a matrix or environment
DE60332158D1 (de) Verfahren zur herzerkrankungsbewertung in einer einzelperson
WO2006117327A3 (en) CELLULAR ASSAY METHOD FOR IDENTIFYING PKC-θ INHIBITORS
DE60326269D1 (de) Verfahren zur detektion von prpsc unter verwendung von gruppe ii aminoglykosid antibiotika

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application